AstraZeneca today announced that the European Medicines Agency has accepted the Marketing Authorisation Variation forForxiga (dapagliflozin), a selective SGLT-2 inhibitor, for use as an oral adjunct treatment to insulin in adults with type-1 diabetes (T1D).
Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.
While infusion pumps are the most widely deployed connected medical devices, they are not the leading cause of security alerts.
Healthcare providers are increasingly looking to EHRs and third-party population health management solutions to help them with value-based care.
The new Cios Select offers many features designed specifically for intraoperative imaging in orthopaedics, trauma surgery, urology, pain management, and peripheral vascular surgery. Credit: Siemens Healthineers.
HealthBot, a healthcare start-up, aims to bring the best of medical services to people staying in remote locations, especially rural areas, through its technology platform.
The Arab Health Exhibition 2018 was successfully held at the Dubai International Convention & Exhibition Centre from January 29th to February 1st, 2018. Ddu, the leading global pharmaceutical & medical device B2B online platform, attended the exhibition along with three priority members, taking home valuable resources.
UAE is world’s fastest growing medical tourism hub with total health expenditure allocation jumping from current USD 23 billion to USD 28 billion by 2021.
Designation Based on Positive Results of Phase 2b Trial of GC4419 Severe Oral Mucositis Affects 70 Percent of Head & Neck Cancer Patients Receiving Radiotherapy
Medical technology company Scandinavian Real Heart has announced that it will be using a range of AdaCore software solutions to develop reliable embedded software for its Total Artificial Heart device.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.